NCT05694988View on ClinicalTrials.gov

Combination of Cytokine Hemosorption and High-volume Hemofiltration in Acute Pancreatitis

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

January 30, 2026

Study Completion Date

April 30, 2026

Conditions
Acute Pancreatitis Without Necrosis or Infection
Interventions
DEVICE

Efferon CT

Efferon CT (JSC Efferon, Moscow, RF) is a device for extracorporeal blood purification by direct hemoperfusion. Detoxification is carried out by sorption of cytokines and other products of endogenous intoxication with a molecular size of up to 55 kDa.

Trial Locations (1)

109263

RECRUITING

V.P. Demikhov City Clinical Hospital No. 68, Moscow

All Listed Sponsors
lead

Efferon JSC

INDUSTRY